Veea Inc. (VEEA) launches $4.353M at-the-market equity sales deal with Roth
Rhea-AI Filing Summary
Veea Inc. entered into an At Market Issuance Sales Agreement with Roth Capital Partners LLC, allowing Veea to issue and sell shares of its common stock from time to time through or to Roth as sales agent or principal. A prospectus supplement filed on August 13, 2026 covers sales of up to $4,353,000 of common stock (the Placement Shares) under an existing effective Form S-3 registration statement.
Roth will use commercially reasonable efforts to sell shares in transactions qualifying as an “at the market offering” under Rule 415. Veea controls the maximum amount to be sold and may set minimum sale prices. Either party may suspend sales or terminate the agreement on five days’ written notice, and the arrangement ends automatically once all Placement Shares are sold. Roth is entitled to 3.0% of the gross proceeds from each sale as compensation. Veea has no obligation to sell any shares and has agreed to provide indemnification and contribution to Roth against certain liabilities.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM capacity: $4,353,000
Sales agent commission: 3.0%
Par value per share: $0.0001
+3 more
6 metrics
ATM capacity
$4,353,000
Aggregate offering price of Placement Shares covered by the prospectus supplement
Sales agent commission
3.0%
Percentage of gross proceeds from each sale of Placement Shares payable to Roth
Par value per share
$0.0001
Par value of Veea’s common stock listed on Nasdaq
Warrant exercise price
$11.50 per share
Each whole warrant exercisable for one share of common stock at this price
Form S-3 file number
333-297083
Registration Statement on Form S-3 used for the ATM offering
Notice period to terminate
5 days
Written notice required by either party to terminate the ATM Agreement
Key Terms
At Market Issuance Sales Agreement, at the market offering, Registration Statement on Form S-3, prospectus supplement, +1 more
5 terms
At Market Issuance Sales Agreement financial
"entered into an At Market Issuance Sales Agreement (the “ATM Agreement”)"
An at market issuance sales agreement is a setup where a company arranges for an agent to sell newly issued shares directly into the public market at the current trading price, usually over time as needed. It matters to investors because it gives the company quick, flexible access to cash without setting a fixed price, but can dilute existing shareholders and affect the stock’s supply and short‑term price behavior—like a shop owner adding extra items to a shelf and selling them at whatever the going price is.
at the market offering financial
"deemed to be an “at the market offering” as defined in Rule 415"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
Registration Statement on Form S-3 regulatory
"under its existing Registration Statement on Form S-3 (File No. 333-297083)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
prospectus supplement regulatory
"filed a prospectus supplement with the Securities and Exchange Commission"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Material Adverse Effect financial
"if there has been a Material Adverse Effect (as such term is defined in the ATM Agreement)"
A material adverse effect is a significant negative change or event that substantially reduces a company’s business, financial condition, or future prospects — think of it like a sudden major engine failure that makes a car unreliable. Investors care because such an event can lower expected profits, trigger contract clauses (allowing counterparties to renegotiate or walk away), and prompt swift stock-price reassessment based on the higher risk and uncertainty.
FAQ
What did Veea Inc. (VEEA) announce regarding new stock issuance?
Veea Inc. entered into an At Market Issuance Sales Agreement with Roth Capital Partners LLC, enabling periodic sales of common stock under an existing Form S-3 registration statement, using an at-the-market structure governed by a filed prospectus supplement.
What is the maximum aggregate amount Veea (VEEA) can sell under the ATM program?
The prospectus supplement covers sales of Veea common stock with an aggregate offering price of up to $4,353,000. These shares, called Placement Shares, may be issued and sold from time to time through or to Roth Capital Partners as sales agent or principal.
How is Roth Capital Partners compensated in Veea’s (VEEA) ATM arrangement?
Roth Capital Partners is entitled to aggregate compensation equal to 3.0% of the gross proceeds from each sale of Placement Shares. This commission applies to shares sold through the agent under the At Market Issuance Sales Agreement executed on August 13, 2026.
Under what registration is Veea’s (VEEA) ATM offering being conducted?
The Placement Shares are being offered and sold under Veea’s existing Registration Statement on Form S-3 (File No. 333-297083), which became effective on July 1, 2026, together with a prospectus and an August 13, 2026 prospectus supplement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
